MapLight Therapeutics, Inc. (MPLT) has 21 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $149K, and 8 sales totalling $11.6M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 16, 2026 | Hanson Kristopher General Counsel | −$192,660 | 16,509 | −11% | Yes | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | Kreitzer Anatol Chief Discovery Officer | $0 | 30,475 | +33% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | Lillie James Woodruff Chief Scientific Officer | $0 | 39,125 | +33% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | Hanson Kristopher General Counsel | $0 | 39,125 | +33% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | GILLIS JONATHAN CAO and Interim CFO | $0 | 35,510 | — | No | |
|
|
||||||
Showing the 5 most recent of 21 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free